Zila Nutraceuticals
This article was originally published in The Tan Sheet
Executive Summary
Ronald Fugate named VP and general manager of Zila Nutraceuticals, Phoenix-based firm announces Sept. 18. Fugate brings experience from J&J, Kellogg Functional Foods Division to post; he most recently served as senior director-marketing at Bristol-Myers Squibb's Consumer Medicines division, where he led Pravachol Rx-to-OTC switch attempt (1"The Tan Sheet" July 24, 2000, p.12). In his new role, Fugate will look to introduce Zila's Ester-C vitamin C ingredient into new vitamin products. In a Sept. 18 conference call, Zila President & CEO Doug Burkett, PhD, said the firm expects to see 25% top line growth for Ester-C in 2002; ingredient recorded roughly $20 mil. in sales in 2001, firm says...